Clinical Trial Update: Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial evaluates decitabine for relapsed or refractory acute myeloid leukemia and acute lymphoblastic leukemia, including AML with maturation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Promyelocytic Leukemia (M3) | Phase 1 | Status: TERMINATED